title: [Study of the efficacy of semax in global cerebral ischemia in vivo].
authors.forename: E V
authors.initials: EV
authors.lastname: Iakovleva
authors.forename: V S
authors.initials: VS
authors.lastname: Kuzenkov
authors.forename: V N
authors.initials: VN
authors.lastname: Fedorov
authors.forename: V I
authors.initials: VI
authors.lastname: Skvortsova
authors.forename: V B
authors.initials: VB
authors.lastname: Koshelev
authors.forename: E I
authors.initials: EI
authors.lastname: Gusev
authors.forename: I P
authors.initials: IP
authors.lastname: Ashmarin
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications; D002545:Brain Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002340:Carotid Artery Diseases / Q000150:complications; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats
chemical_list: D018696:Neuroprotective Agents; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone